69 related articles for article (PubMed ID: 3277488)
1. Improvement of walking distance in patients with intermittent claudication by chronic local therapy with isosorbide dinitrate ointment.
Testa R; Biagini A; Michelassi C; Emdin M; Mazzei MG; Carpeggiani C; l'Abbate A
Angiology; 1988 Jan; 39(1 Pt 1):1-7. PubMed ID: 3277488
[TBL] [Abstract][Full Text] [Related]
2. [Isosorbide dinitrate ointment in the long-term treatment of intermittent claudication].
Testa R; Biagini A; Carpeggiani C; Mazzei MG; Michelassi C; Emdin M; L'Abbate A
G Ital Cardiol; 1984 Nov; 14(11):852-8. PubMed ID: 6526201
[TBL] [Abstract][Full Text] [Related]
3. [Intermittent claudication: topical treatment with isosorbide dinitrate ointment. Preliminary results].
Biagini A; Carpeggiani C; Testa R; Mazzei MG; Michelassi C; L'Abbate A
G Ital Cardiol; 1981; 11(7):983-9. PubMed ID: 7308655
[TBL] [Abstract][Full Text] [Related]
4. A long-term study of policosanol in the treatment of intermittent claudication.
Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
[TBL] [Abstract][Full Text] [Related]
5. Effects of pentoxifylline on severe intermittent claudication.
Reich T; Gillings D
Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
[TBL] [Abstract][Full Text] [Related]
6. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
7. [Intermittent claudication: effect of local treatment with isosorbide dinitrate paste].
Carpeggiani C; Testa R; Mazzei MG; Michelassi C; Biagini A; L'Abbate A
Boll Soc Ital Cardiol; 1981; 26(10):1323-30. PubMed ID: 7349161
[No Abstract] [Full Text] [Related]
8. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
Cameron HA; Waller PC; Ramsay LE
Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
[TBL] [Abstract][Full Text] [Related]
9. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
Blume J; Kieser M; Hölscher U
Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
[TBL] [Abstract][Full Text] [Related]
10. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
[TBL] [Abstract][Full Text] [Related]
11. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
Kieffer E; Bahnini A; Mouren X; Gamand S
Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
[TBL] [Abstract][Full Text] [Related]
12. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
13. Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications.
Arcan JC; Blanchard J; Boissel JP; Destors JM; Panak E
Angiology; 1988 Sep; 39(9):802-11. PubMed ID: 3048155
[TBL] [Abstract][Full Text] [Related]
14. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
16. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
[TBL] [Abstract][Full Text] [Related]
18. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
19. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
Gresele P; Migliacci R; Di Sante G; Nenci GG;
Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584
[TBL] [Abstract][Full Text] [Related]
20. [Transcutaneous application of nitroglycerin and isosorbide dinitrate versus placebo: effect in myocardial ischemia].
Gloor HO; Angehrn W; Steinbrunn W
Schweiz Med Wochenschr; 1985 Mar; 115(12):412-7. PubMed ID: 3922052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
